PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 131 filers reported holding PROGENICS PHARMACEUTICALS IN in Q4 2019. The put-call ratio across all filers is 1.40 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $1,000 | -66.7% | 100 | -77.4% | 0.00% | – |
| Q2 2019 | $3,000 | -72.7% | 443 | -81.5% | 0.00% | -100.0% |
| Q1 2019 | $11,000 | – | 2,390 | +2176.2% | 0.00% | – |
| Q4 2018 | $0 | -100.0% | 105 | -40.7% | 0.00% | – |
| Q3 2018 | $1,000 | – | 177 | – | 0.00% | – |
| Q3 2017 | $0 | -100.0% | 0 | -100.0% | 0.00% | – |
| Q2 2017 | $2,000 | -94.4% | 252 | -93.5% | 0.00% | -100.0% |
| Q1 2017 | $36,000 | +24.1% | 3,854 | +13.0% | 0.00% | +33.3% |
| Q4 2016 | $29,000 | +262.5% | 3,412 | +178.5% | 0.00% | +200.0% |
| Q3 2016 | $8,000 | +300.0% | 1,225 | +121.1% | 0.00% | – |
| Q1 2016 | $2,000 | -95.2% | 554 | -91.8% | 0.00% | -100.0% |
| Q4 2015 | $42,000 | +1300.0% | 6,779 | +1029.8% | 0.01% | – |
| Q3 2015 | $3,000 | -94.0% | 600 | -91.1% | 0.00% | -100.0% |
| Q2 2015 | $50,000 | -24.2% | 6,747 | -39.4% | 0.00% | -50.0% |
| Q1 2015 | $66,000 | +725.0% | 11,138 | +977.2% | 0.01% | +700.0% |
| Q4 2014 | $8,000 | -11.1% | 1,034 | -49.3% | 0.00% | 0.0% |
| Q2 2014 | $9,000 | -30.8% | 2,041 | -34.9% | 0.00% | -50.0% |
| Q1 2014 | $13,000 | -55.2% | 3,134 | -44.9% | 0.00% | -33.3% |
| Q3 2013 | $29,000 | +2800.0% | 5,687 | +2743.5% | 0.00% | – |
| Q2 2013 | $1,000 | – | 200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|